| |
0–6 h
|
6–72 h
|
0–72 h
|
---|
Author
| |
EGDT
|
Usual care
|
P
|
EGDT
|
Usual care
|
P
|
EGDT
|
Usual care
|
P
|
---|
Wang [45]
|
Intravenous fluids (ml)
|
4895 ± 210a
|
2340 ± 95a
|
0.01
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
Rivers [7]
|
Intravenous fluids (ml)
|
4981 ± 2984a
|
3499 ± 2438a
|
0.001
|
8625 ± 5162a
|
10602 ± 6216a
|
0.01
|
13443 ± 6390a
|
13358 ± 7729a
|
0.73
|
|
Vasopressor use
|
32/117
|
36/119
|
0.62
|
34/117
|
51/119
|
0.03
|
43/117
|
61/119
|
0.02
|
|
Dobutamine use
|
16/117
|
1/119
|
0.001
|
17/117
|
10/119
|
0.14
|
18/117
|
11/119
|
0.15
|
|
Blood transfusion
|
75/117
|
22/119
|
0.001
|
13/117
|
39/119
|
0.001
|
80/117
|
53/119
|
0.001
|
ProCESS [6]
|
Intravenous fluids (ml)
|
2805 ± 1957a
|
2279 ± 1881a
|
0.0001
|
4458 ± 3878a
|
4354 ± 3882a
|
0.08
|
7253 ± 4605a
|
6633 ± 4560a
|
0.0001
|
|
Vasopressor use
|
241/439
|
201/456
|
0.003
|
209/439
|
197/456
|
0.38
|
265/439
|
245/456
|
0.05
|
|
Dobutamine use
|
35/439
|
4/456
|
0.0001
|
19/439
|
10/456
|
0.08
|
41/439
|
13/456
|
0.0001
|
|
Blood transfusion
|
63/439
|
34/456
|
0.001
|
87/439
|
82/456
|
0.54
|
120/439
|
102/456
|
0.22
|
ARISE [30]
|
Intravenous fluids (ml)
|
1964 ± 1415a
|
1713 ± 1401a
|
0.001
|
4274 ± 3071a
|
4382 ± 3136a
|
0.51
|
NA
|
NA
|
NA
|
|
Vasopressor use
|
528/793
|
461/798
|
0.001
|
460/782
|
401/778
|
0.004
|
NA
|
NA
|
NA
|
|
Dobutamine use
|
122/793
|
21/798
|
0.001
|
74/782
|
39/788
|
0.001
|
NA
|
NA
|
NA
|
|
Blood transfusion
|
108/793
|
56/798
|
0.001
|
86/782
|
92/778
|
0.61
|
NA
|
NA
|
NA
|
ProMISe [31]
|
Intravenous fluids (ml)
|
2226 ± 1443a
|
2022 ± 1271
|
NA
|
4215 ± 3068a
|
4366 ± 3114
|
NA
|
5946 ± 3740a
|
5844 ± 3651a
|
NA
|
|
Vasopressor use
|
332/623
|
291/625
|
NA
|
349/603
|
317/603
|
NA
|
377/623
|
344/625
|
NA
|
|
Dobut mine use
|
113/623
|
24/625
|
NA
|
107/603
|
39/603
|
NA
|
139/623
|
44/625
|
NA
|
|
Blood transfusion
|
55/623
|
24/625
|
NA
|
76/603
|
51/603
|
NA
|
107/623
|
65/625
|
NA
|
-
NA no available, P P value
-
amean ± standard deviation